Yesterday | Theflyonthewall.com
Dara BioSciences: new organizational responsibilities ahead of product launches
DARA BioSciences announced several key changes in its organizational structure. These changes afford DARA the opportunity to better position the company for growth as it prepares for the launch of two new products.
DARA BioSciences, Inc. Reports Financial Results for the First...
HOTBEDS Regional News US & Canada Biotech Bay Biotech Beach Genetown Pharm Country BioCapital BioMidwest Bio NC BioForest Southern Pharm BioCanada East US Device Europe Asia DARA BioSciences, Inc.
DARA BioSciences Announces New Analysis of Patient Self-Reported...
DARA BioSciences Announces New Analysis of Patient Self-Reported Diary Results in a Phase 2a Clinical Trial of KRN5500 in Patients With Cancer and Neuropathic Pain RALEIGH, N.C., May 9, 2012 -- DARA BioSciences, Inc.
Dara raises $10.25M to launch drugs
Dara BioSciences, Inc. David Drutz says the financing will fund the commercial launches of breast cancer drug Soltamax and oncology radiation drug Bionect.